GC Biopharma

GC Biopharma EBIT per Share

The EBIT per Share of GC Biopharma (006280.KS) as of Oct 11, 2026 is 6,058.76 KRW. In the previous year, EBIT per Share was 2,813.18 KRW — a change of 115.37% (higher).

EBIT per Share

6,058.76KRW

YoY

115.37%

Last updated:

EBIT per Share of GC Biopharma is 2025 6,058.76 KRW. EBIT per Share of GC Biopharma was 2024 2,813.18 KRW. It decreases by 115.37% higher compared to the previous year.

The GC Biopharma EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2021
6,460.56 KRW
Jan 1, 2022
8,819.05 KRW
Jan 1, 2023
3,017.66 KRW
Jan 1, 2024
2,813.18 KRW
Jan 1, 2025
6,058.76 KRW
Jan 1, 2026 (e)
0.00 KRW
Jan 1, 2027 (e)
11,818.23 KRW
Jan 1, 2028 (e)
14,576.35 KRW
The GC Biopharma EBIT per Share history
YEAREBIT per ShareYoY
est14,576.35KRW+23.34%
est11,818.23KRW—
est0.00KRW-100.00%
6,058.76KRW+115.37%
2,813.18KRW-6.78%
3,017.66KRW-65.78%
8,819.05KRW+36.51%
6,460.56KRW+46.64%
4,405.82KRW+24.79%
3,530.52KRW-19.80%
4,402.07KRW+110.33%
2,092.89KRW-69.24%
6,805.01KRW-15.26%
8,030.81KRW-5.47%
8,495.94KRW+23.04%
6,905.03KRW+5.99%
6,514.88KRW-12.92%
7,481.35KRW-41.37%
12,759.67KRW+6.88%
11,938.80KRW+75.75%
6,793.20KRW+16.23%
5,844.60KRW+21.58%
4,807.08KRW—
Access this data via the Eulerpool API
Get Free API Key

GC Biopharma Stock analysis

What does GC Biopharma do? GC Biopharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about GC Biopharma stock

EBIT per Share of GC Biopharma is 6,058.76 KRW in 2025.

EBIT per Share of GC Biopharma changed from 2,813.18 KRW to 6,058.76 KRW, representing a 115.37% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share GC Biopharma since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — GC Biopharma

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — GC Biopharma